GHK-Cu Providers, Compared on Price and Pharmacy Transparency
10 providers, each read directly off its own site — 1 publish no price for GHK-Cu at all, and only 7 name their pharmacy and state a regulatory category on the GHK-Cu page itself.
On this page▾
/ The board
Any paid placement here is marked Partner and listed first, as a disclosed commercial position — within that group, and separately within every other row, every provider is still ranked on the criteria printed on this page, never anything else (see disclosure). Full write-ups below.
Good fit if paying cash, FSA, or HSA works for you, since Empower doesn't accept insurance anyway.
PriceNot published
Starting-at priceLabs: Not applicable — Empower fills a prescription an outside clinician already wrote; it runs no consult or labs program of its own.503A pharmacyNo dietitian
“Flat price” means one all-in monthly figure with no separate membership or lab fee; any other pricing chip names the mechanic that gets in the way, or that the provider has not stated one. “Labs” is whether bloodwork is required, optional, not used, or not stated on the provider's own site. The pharmacy chip states a facility type (503A pharmacy, 503B facility, or 503A + 503B network where a company names pharmacies in both categories) only where the provider publishes one we could cite; “Not disclosed” means we read their site and they do not say, and “Unverified” means nobody has checked this company's pharmacy sourcing yet — of the 10 providers listed, 7 publish a facility type at all. Every provider here includes the clinician consult. Each row above shows the exact date its price was checked on that provider's own site — prices can change without notice.
Every provider read live off its own site by August 2026, ranked by the same criteria as the board above: pharmacy disclosure first, then advertised price, low to high. #1 is our top pick on those criteria — filter to see the rest a different way.
All 10, by pharmacy disclosure then price
1
Eden
Eden's own site now states "From $68/month" for GHK-Cu Foam — down from the $83/mo it charged before — plus a separate required Eden Membership fee, stated plainly here rather than folded into one blended number.
Bodybuilding Health+ fronts GHK-Cu Topical with a "$99/mo first month" figure that steps up to $149/mo afterward — the same first-month-teaser pattern already documented on its other rows, and names no pharmacy anywhere on the site.
Names FOUR pharmacies outright (Pharmacy Innovations, Sweetgrass Pharmacy & Compounding, Absolute Pharmacy, Striker Pharmacy) and states the category with them: "licensed 503A pharmacies, not 503B outsourcing facilities"
PreventiveMD prices GHK-Cu "as low as $89/mo, all-in" and states a direct, unhedged regulatory-category claim on its homepage, though no specific pharmacy is named.
YourHealthRx states, unhedged, exactly which federal regulatory category its compounding pharmacies fall under, and prices GHK-Cu "as low as $175/mo" — though no specific pharmacy is named for it.
RxPepsDirect names its compounding pharmacy (Optimal Balance Pharmacy) and states a regulatory category for it directly on the same page that states the price and prices GHK-Cu at $80 per 50mg, the lowest per-unit figure here.
Vyora Wellness's own GHK-Cu Cream page now states a plain "$199.00/month" — a figure it did not publish at all until recently — but it frames the product as a "cosmetic topical" without restating its sitewide regulatory-category claim on that specific page.
A real, flat, unhedged $199/mo price is now published, where the same-week audit found none — a genuine improvement in transparency this board records honestly
Empower Pharmacy IS the compounding pharmacy, not a telehealth company naming one — the most directly self-identified regulated compounding facility here — but publishes no price for GHK-Cu anywhere, and runs no consult program of its own.
Empower Pharmacy publishes no price for this compound.
States its own regulatory category directly and unhedged, as the compounding pharmacy itself rather than a reseller naming one — see the model note for the exact quote
What determines a row's position is printed below, and nothing else moves it: a commercial relationship can earn a provider a disclosed, labeled placement, but it cannot change the criteria, the verified prices, or the drawbacks we print beside any row. The 3 factors below are what actually move a row up or down.
Two prices changed between the audit and this pass
1 of the 10 providers here publish no price for GHK-Cu anywhere on their own site right now. 4 more quote only a "starting at," "as low as," or first-month figure with no full dose-tier breakdown. Re-checking every row live, rather than sampling, caught two real changes since the source audit: Eden's price moved and now carries a separately disclosed membership fee, and Vyora Wellness went from no published price to a flat $199/mo. Both are stated here as found, not smoothed over.
Pharmacy sourcing, on the record or not
We only mark a provider's pharmacy chip with a regulatory facility category when its own site names the facility AND states that category — of the 10 providers here, 7 do. Several of the rest state a 503A claim sitewide without restating it on the GHK-Cu product page itself — a real, checkable gap, not an oversight on our part.
How the order is set
Any paid placement is marked Partner and listed first, as a disclosed commercial position — see the disclosure below the board. Within that group, and separately within every other row, the same rule applies: sorted by whether the provider clears the pharmacy-disclosure bar above, then by their own advertised price, low to high, for rows that tie. A provider's placement within its own group is never for sale.
Before you compare prices: unlike this site's tirzepatide and semaglutide boards — where a compounded version is sold specifically because an FDA-approved brand (Zepbound, Wegovy) is in shortage — GHK-Cu has no FDA-approved drug product of any kind. A direct DailyMed search for "GHK-Cu" (checked live, August 2026) returns exactly one result: an over-the-counter sunscreen marketed under an OTC monograph, where "copper tripeptide-1" appears only as an inactive ingredient — not the product's active sunscreen agent, and not a GHK-Cu product in any real sense. No injectable or topical GHK-Cu product exists on DailyMed at all. Every provider here is a compounded wellness product sold under a pharmacy's general compounding authority, with no DailyMed-listed precedent this check could find. What we score here is how honestly and clearly each provider states its price and pharmacy sourcing — not whether GHK-Cu itself is worth buying. Talk to a licensed clinician about that part.
Only confirmed GHK-Cu sellers are ranked here. Looking for a related wellness compound instead? Our PT-141 comparison shares three providers with this roster (Bodybuilding Health+, RxPepsDirect, YourHealthRx) but is not the same list — a provider selling GHK-Cu does not necessarily sell PT-141, and vice versa. Our NAD+ and Glutathione comparisons use the same pharmacy-first method against different longevity-compound rosters. Looking for a GLP-1 or growth-hormone-axis peptide instead? Our tirzepatide comparison and sermorelin comparison round out the rest — see each board's own roster for what it actually confirmed.
Nothing on this page is medical advice. GHK-Cu is not an FDA-approved drug in any form we could find; every product here is sold as a compounded or wellness formulation under a pharmacy's general authority, not a medication reviewed by FDA for the safety or efficacy of this specific use. We read every price and sourcing claim on this page directly off each provider's own site by August 2026; providers change prices without telling us, so verify the current number before you buy. Ask a licensed clinician whether GHK-Cu fits your situation.
